BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 22305990)

  • 1. The spatial distribution of age-related white matter changes as a function of vascular risk factors--results from the LADIS study.
    Rostrup E; Gouw AA; Vrenken H; van Straaten EC; Ropele S; Pantoni L; Inzitari D; Barkhof F; Waldemar G;
    Neuroimage; 2012 Apr; 60(3):1597-607. PubMed ID: 22305990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of death in community-dwelling older people with white matter hyperintensities on MRI.
    Kerber KA; Whitman GT; Brown DL; Baloh RW
    J Neurol Sci; 2006 Dec; 250(1-2):33-8. PubMed ID: 16889799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
    Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
    J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of white matter hyperintensities in elderly individuals over 3 years.
    Sachdev P; Wen W; Chen X; Brodaty H
    Neurology; 2007 Jan; 68(3):214-22. PubMed ID: 17224576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular risk factors, white matter hyperintensities and hippocampal volume in normal elderly individuals.
    Gattringer T; Enzinger C; Ropele S; Gorani F; Petrovic KE; Schmidt R; Fazekas F
    Dement Geriatr Cogn Disord; 2012; 33(1):29-34. PubMed ID: 22377559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
    Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
    Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging age-related cognitive decline: A comparison of diffusion tensor and magnetization transfer MRI.
    Schiavone F; Charlton RA; Barrick TR; Morris RG; Markus HS
    J Magn Reson Imaging; 2009 Jan; 29(1):23-30. PubMed ID: 19097099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.
    Yoshita M; Fletcher E; Harvey D; Ortega M; Martinez O; Mungas DM; Reed BR; DeCarli CS
    Neurology; 2006 Dec; 67(12):2192-8. PubMed ID: 17190943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study.
    Verdelho A; Madureira S; Moleiro C; Ferro JM; Santos CO; Erkinjuntti T; Pantoni L; Fazekas F; Visser M; Waldemar G; Wallin A; Hennerici M; Inzitari D;
    Neurology; 2010 Jul; 75(2):160-7. PubMed ID: 20625169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of white matter integrity is associated with gait disorders in cerebral small vessel disease.
    de Laat KF; Tuladhar AM; van Norden AG; Norris DG; Zwiers MP; de Leeuw FE
    Brain; 2011 Jan; 134(Pt 1):73-83. PubMed ID: 21156660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon Study.
    Satizabal CL; Zhu YC; Mazoyer B; Dufouil C; Tzourio C
    Neurology; 2012 Mar; 78(10):720-7. PubMed ID: 22357713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients.
    Tseng YL; Chang YY; Liu JS; Su CS; Lai SL; Lan MY
    J Neurol Sci; 2009 Sep; 284(1-2):36-9. PubMed ID: 19398115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid and brain ischemia in normal elderly adults.
    Schretlen DJ; Inscore AB; Vannorsdall TD; Kraut M; Pearlson GD; Gordon B; Jinnah HA
    Neurology; 2007 Oct; 69(14):1418-23. PubMed ID: 17909154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral changes on MRI and cognitive function: the CASCADE study.
    Söderlund H; Nilsson LG; Berger K; Breteler MM; Dufouil C; Fuhrer R; Giampaoli S; Hofman A; Pajak A; de Ridder M; Sans S; Schmidt R; Launer LJ
    Neurobiol Aging; 2006 Jan; 27(1):16-23. PubMed ID: 16298236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTI of white matter hyperintensities.
    Fazekas F; Ropele S; Enzinger C; Gorani F; Seewann A; Petrovic K; Schmidt R
    Brain; 2005 Dec; 128(Pt 12):2926-32. PubMed ID: 15958507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased rates of white matter hyperintensities in late-onset bipolar disorder.
    Tamashiro JH; Zung S; Zanetti MV; de Castro CC; Vallada H; Busatto GF; de Toledo Ferraz Alves TC
    Bipolar Disord; 2008 Nov; 10(7):765-75. PubMed ID: 19032708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample.
    Wen W; Sachdev PS; Chen X; Anstey K
    Neuroimage; 2006 Feb; 29(4):1031-9. PubMed ID: 16253521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral white matter lesions in patients with Crohn's disease.
    Chen M; Lee G; Kwong LN; Lamont S; Chaves C
    J Neuroimaging; 2012 Jan; 22(1):38-41. PubMed ID: 21091817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular risk factors and white matter hyperintensities in patients with amnestic mild cognitive impairment.
    Sepe-Monti M; Pantano P; Vanacore N; De Carolis A; Bianchi V; Antonini G; Guidoni SV; Giubilei F
    Acta Neurol Scand; 2007 Jun; 115(6):419-24. PubMed ID: 17511852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.